Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the Literature

Intern Med. 2023;62(11):1647-1652. doi: 10.2169/internalmedicine.0599-22. Epub 2023 Jun 1.

Abstract

We herein report an 83-year-old woman with filgrastim-associated aortitis during chemotherapy for relapsed diffuse large B-cell lymphoma. She had been treated with filgrastim as a prophylaxis for neutropenia during the fourth cycle of chemotherapy from day 9 to 18. On day 21, she developed a fever. Contrast-enhanced computed tomography revealed aortitis of the descending aorta. The fever abated with non-steroidal anti-inflammatory drug treatment. A literature review identified a small number of aortitis cases all caused by prophylactic use of granulocyte colony-stimulating factors (G-CSFs), among which short-acting filgrastim was rarely encountered. The present and previous findings imply a possible relationship between aortitis and prophylactic G-CSF usage.

Keywords: aortitis; granulocyte colony-stimulating factor; long-acting G-CSF; non-Hodgkin lymphoma; prophylactic treatment; short-acting G-CSF.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Aortitis* / chemically induced
  • Aortitis* / diagnostic imaging
  • Aortitis* / drug therapy
  • Female
  • Fever / drug therapy
  • Filgrastim / adverse effects
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Humans
  • Neoplasms* / drug therapy
  • Neutropenia* / drug therapy

Substances

  • Filgrastim
  • Granulocyte Colony-Stimulating Factor